EP
Eversept Partners Portfolio holdings
AUM
$992M
This Quarter Return
+3.05%
1 Year Return
+2.54%
3 Year Return
+103.47%
5 Year Return
+181.01%
10 Year Return
–
AUM
$1.25B
AUM Growth
+$1.25B
(+15%)
Cap. Flow
+$156M
Cap. Flow
% of AUM
12.52%
Top 10 Holdings %
Top 10 Hldgs %
49.35%
Holding
117
New
34
Increased
30
Reduced
22
Closed
15
Top Buys
| 1 |
Labcorp
LH
|
$36.1M |
| 2 |
Ascendis Pharma
ASND
|
$32.4M |
| 3 |
Community Health Systems
CYH
|
$25.3M |
| 4 |
CTLT
CATALENT, INC.
CTLT
|
$24.5M |
| 5 |
Icon
ICLR
|
$18.8M |
Top Sells
| 1 |
Qiagen
QGEN
|
$26.2M |
| 2 |
AMRN
Amarin Corp
AMRN
|
$25.8M |
| 3 |
Organon & Co
OGN
|
$21.2M |
| 4 |
Danaher
DHR
|
$17.3M |
| 5 |
AMN Healthcare
AMN
|
$17.1M |
Sector Composition
| 1 | Healthcare | 93.33% |
| 2 | Industrials | 1.35% |
| 3 | Financials | 0.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Intuitive Surgical
ISRG
$170B
| $3.13M | 0.22% | 3,145 +562 | +22% | +$559K |
|
52
Evolent Health
EVH
$1.12B
| $3.11M | 0.21% | +100,170 | New | +$3.11M |
|
|
KRTX
53
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $3.06M | 0.21% | +25,000 | New | +$3.06M |
|
54
Agilent Technologies
A
$35.7B
| $2.94M | 0.2% | 18,660 +3,399 | +22% | +$535K |
|
55
Puma Biotechnology
PBYI
$254M
| $2.79M | 0.19% | +397,940 | New | +$2.79M |
|
56
Viridian Therapeutics
VRDN
$1.5B
| $2.63M | 0.18% | +160,000 | New | +$2.63M |
|
|
AUTL
57
Autolus Therapeutics
AUTL
$399M
| $2.61M | 0.18% | 398,074 -75,000 | -16% | -$491K |
|
58
Liquidia Corp
LQDA
$2.38B
| $2.56M | 0.18% | 929,049 -50,000 | -5% | -$138K |
|
|
MORF
59
DELISTED
Morphic Holding, Inc. Common Stock
MORF
| $2.47M | 0.17% | +43,600 | New | +$2.47M |
|
60
Outset Medical
OM
$247M
| $2.35M | 0.16% | 47,500 -59,800 | -56% | -$2.96M |
|
|
ADAP
61
Adaptimmune Therapeutics
ADAP
$15.6M
| $2.3M | 0.16% | +444,887 | New | +$2.3M |
|
62
HealthStream
HSTM
$832M
| $2.22M | 0.15% | 77,812 | – | – |
|
|
MREO
63
Mereo BioPharma
MREO
$272M
| $2.18M | 0.15% | +899,569 | New | +$2.18M |
|
64
AnaptysBio
ANAB
$569M
| $2.12M | 0.15% | +78,054 | New | +$2.12M |
|
|
TECX
65
Tectonic Therapeutic, Inc. Common Stock
TECX
$478M
| $2.01M | 0.14% | +359,480 | New | +$2.01M |
|
66
Gossamer Bio
GOSS
$562M
| $1.88M | 0.13% | +149,910 | New | +$1.88M |
|
67
Myomo
MYO
$39.7M
| $1.78M | 0.12% | +150,000 | New | +$1.78M |
|
68
argenx
ARGX
$43.6B
| $1.74M | 0.12% | +5,746 | New | +$1.74M |
|
|
MRTX
69
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $1.65M | 0.11% | +9,355 | New | +$1.65M |
|
70
IQVIA
IQV
$32.4B
| $1.63M | 0.11% | 6,790 +1,078 | +19% | +$258K |
|
|
LOGC
71
DELISTED
LogicBio Therapeutics, Inc. Common Stock
LOGC
| $1.6M | 0.11% | +349,919 | New | +$1.6M |
|
72
AC Immune
ACIU
$205M
| $1.49M | 0.1% | +221,749 | New | +$1.49M |
|
73
Dianthus Therapeutics
DNTH
$759M
| $1.45M | 0.1% | +198,879 | New | +$1.45M |
|
|
ORTX
74
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
| $1.31M | 0.09% | +569,581 | New | +$1.31M |
|
|
AKYA
75
DELISTED
Akoya BioSciences
AKYA
| $1.28M | 0.09% | +91,568 | New | +$1.28M |
|